Dr Reddy's Laboratories received a major setback in the US, as a court there granted a motion seeking a preliminary injunction to block the launch of its generic version of Sanofi-Aventis' anti-allergic drug, Allegra D24.
In the growth years of 2005 to 2008,companies were busy shopping abroad to expand their global footprint. It's the turn of overseas companies now to buy Indian assets aggressively.
The Clinical Research sector is emerging as an attractive option for science graduates, doctors, management/ IT professionals, alike.
Medical experts have warned that the volume of vaccine available to fight the coronavirus or SARS-CoV-2 in coming years is expected to fall far short of global demand, despite an unprecedented effort to manufacture billions of doses.
Despite the best efforts of Indian vaccine makers to develop the H1N1(swine flu) vaccine, Swiss drug major Novartis and Australian vaccine maker CSL may be the first ones to bag the orders from the central government for its supply.
The initiative will include special training for Customs and drug regulatory officials to identify spurious drugs, their origin, distribution chain and follow-up action to raid premises and book culprits, in coordination with regulatory and police officials of various countries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Aventis Pharma, the Indian arm of sanofi-aventis, the world's third largest drug company, is planning to ramp up its domestic operations with acquisition of brands and make India a major hub for its research and development and manufacturing activities. At present, sanofi-aventis has two large manufacturing facilities, one at Ankleswar for active pharmaceutical ingredients and the other in Goa for making tablets.
The medicines whose prices have been reduced belong to therapeutic categories, like dexametozone, betamethazone, ampicillin and ranitidine. The prices of some multi-vitamins and antibiotics would rise a bit.
'Is it advisable to have more number of scrips in small quantities or a few scrips in big quantities?'
Ranbaxy Laboratories, Dr Reddy's Laboratories and Sun Pharma's US subsidiary Caraco Pharmaceuticals are among the 13 generic manufacturers to get first generic approvals from the US Food and Drug Administration to manufacture and market generic versi
Eli Lily, Sanofi Aventis, Bristol Myers approach chemicals ministry.
A probe finds several pharma majors in breach of the law; and in turn they blame the government.
Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual property.
The company said it will appoint a new Chairman at the next Board meeting.
India set to become hub for clinical trials
Hyderabad based Dr Reddy's Laboratories has received approval from the US Food and Drugs Administration for multiple strengths of anti-diabetes drug glimepiride tablets.
Investors must carefully watch the developments on the MNC pipeline.
Currently, the govt directly caps prices of 348 formulations at the average price of all medicines in a particular segment with at least 1% market share
It is advisable to stick to mid-caps with sustainable financial metrics rather than those offering the promise of faster growth.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The FIPB on Friday cleared the long-pending proposal of HDFC Bank to hike foreign holding in the bank to 74 per cent.
FDI in drugs and pharmaceuticals was $487 million during April-August 2012, according to the latest data of the Department of Industrial Policy and Promotion.
Mumbai-based BabyChakra is among the four start-ups Google has shortlisted from India for the fifth batch of its mentorship programme
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
.jpg)
The Drugs Controller General of India is considering the recommendations of its advisory body to revoke the suspension of the sale of analgin-based medicines in the country.
According to assurance, tax and advisory firm Grant Thornton, corporates in the country announced 458 deals in the January-November period amounting to $26.76 billion.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Western drugmakers, including Pfizer Inc, Novartis AG, Roche Holding AG and Sanofi SA, covet a bigger share of the fast-growing Indian drugs market.
Ties between India and the United States have been strained in recent years because of trade policies and patent disputes.
.jpg)
Firms are mandated to change prices of medicines within 45 days of NPPA's notification.
Kolkata-based United Bank of India, which had earlier declared Kingfisher Airlines and its four directors, including Mallya as wilful defaulters, on Tuesday identified UBHL, the guarantor of the grounded Kingfisher Airlines, also a wilful defaulter.
n the broader market, both the BSE Midcap and Smallcap indices, were up 1.2% and 0.7% each.
Analysts are divided on the deal valuations. Some say Torrent could have bargained harder, as Sanofi, among others, passed it over.
Bharat Biotech started work on developing a vaccine against Zika way back in 2014.
Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances